IP Library Granted Patent US 8,012,694
Granted Patent B2
US 8,012,694 · App. 11/521,007 · Granted Sep 6, 2011

Assay for the detection of phosphorylated PTH

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,012,694
App. No.
11/521,007
Granted
Sep 6, 2011
Kind
B2
Abstract

Antibodies for a variant of intact parathyroid hormone (PTH) or its fragments which have at position 17 the amino acid serine which is phosphorylated [p(17) PTH] and methods of producing the same. The invention further includes various immunoassay methods which use the described antibody alone or in combination with other antibodies to determine the circulating levels of p(17) intact PTH (1-84) or fragments thereof in biological fluids. Such antibodies and immunoassays can be used in conjunction with other antibodies to detect all biologically active forms of hPTH present in biological fluids.

Claims (10)

1. An isolated antibody or an antigen binding fragment thereof that specifically binds to human parathyroid hormone (SEQ ID NO. 1) having a phosphorylated serine amino acid at position 17.

2. The antibody or antibody fragment of claim 1 wherein the antibody or antigen binding fragment thereof specifically binds to human parathyroid hormone at an epitope consisting of amino acids 13-22 (SEQ ID NO. 2).

3. A method for producing antibodies useful in the determination of PTH levels in a biological sample, wherein the PTH has a phosphorylated serine amino acid at position 17 the method comprising the steps:

a. administering a first peptide antigen to a host animal to induce antibody production against said first peptide antigen in the host animal wherein said first peptide antigen comprises amino acids 13-22 (SEQ ID NO. 2) of human PTH (SEQ ID NO. 1), wherein the amino acid serine present at the seventeenth residue in said PTH and wherein said serine is phosphorylated;

b. monitoring antibody titer produced by the administration of said first peptide antigen to the host animal;

c. extracting antisera produced in said host animal;

d. subjecting the antisera extracted in step c) to affinity chromatography utilizing a second peptide antigen, wherein said second peptide antigen is a bioactive form of PTH selected from the group consisting of PTH (1-34) (SEQ ID NO. 4) and PTH (1-84) (SEQ ID NO. 1) wherein the bioactive form of PTH has a phosphorylated serine amino acid at position 17, to recover the antibodies from said antisera that have affinity for said second peptide antigen; and

e. subjecting said antibodies recovered in step d) to affinity chromatography utilizing a third peptide antigen, wherein said third peptide antigen is a non-phosphorylated form of bioactive PTH selected from the group consisting of PTH (1-34) (SEQ ID NO. 4) and PTH (1-84) (SEQ ID NO. 1), to recover at least one antibody that does not have affinity for said third peptide antigen.

4. The method of claim 3 wherein said first peptide antigen in step a) is coupled to a carrier protein.

5. An isolated antibody produced by the method of claim 3 .

Assignments (7)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: IMMUTOPICS, INC.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0916 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION
Reel/Frame 060220/0649 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Oct 6, 2017
From: QUIDEL CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 044141/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2008
From: LAVIGNE, JEFFREY R.; ZAHRADNIK, RICHARD J.
To: IMMUTOPICS, INC.
Reel/Frame 021915/0694 →